BIOMAT Database Logo BIOMAT Database Logo

[Phenytoin serum concentration in epileptic patients: influence of therapeutic and physiological factors (author's transl)]. 1982

T May, and E Stenzel, and B Rambeck

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T May, and E Stenzel, and B Rambeck
[Pharmacological influence of valproate on phenobarbitone and phenytoin serum concentrations in epileptic patients (author's transl)].
November 1979, Der Nervenarzt,
T May, and E Stenzel, and B Rambeck
[SERUM PHENYTOIN CONCENTRATION IN EPILEPTIC OUTPATIENTS].
February 1964, Ugeskrift for laeger,
T May, and E Stenzel, and B Rambeck
"Therapeutic" serum concentration of phenytoin: the influence of seizure type.
March 1984, Journal of neurology, neurosurgery, and psychiatry,
T May, and E Stenzel, and B Rambeck
Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.
July 1979, British journal of clinical pharmacology,
T May, and E Stenzel, and B Rambeck
Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients.
June 1975, British journal of clinical pharmacology,
T May, and E Stenzel, and B Rambeck
Factors influencing serum concentration of zonisamide in epileptic patients.
January 1992, Chemical & pharmaceutical bulletin,
T May, and E Stenzel, and B Rambeck
Phenytoin serum concentration monitoring during pregnancy and puerperium in Mexican epileptic women.
January 1995, Archives of medical research,
T May, and E Stenzel, and B Rambeck
[Serum enzyme pattern in epileptic seizures (author's transl)].
November 1977, Der Nervenarzt,
T May, and E Stenzel, and B Rambeck
[Normal values of serum lipids-physiological variance and influencing factors (author's transl)].
March 1976, Rinsho byori. The Japanese journal of clinical pathology,
T May, and E Stenzel, and B Rambeck
[The serum concentration of anticonvulsants -- pharmacokinetic findings and practical therapeutic applications (author's transl)].
September 1979, Wiener klinische Wochenschrift,
Copied contents to your clipboard!